Twin Peaks Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$676K Buy
2,767
+214
+8% +$49.8K 0.17% 90
2025
Q4
$609K Buy
2,553
+558
+28% +$110K 0.18% 90
2025
Q3
$370K Buy
1,995
+149
+8% +$25.5K 0.13% 117
2025
Q2
$319K Buy
1,846
+126
+7% +$19.4K 0.1% 123
2025
Q1
$264K Buy
+1,720
New +$269K 0.12% 114
2024
Q4
Sell
-1,764
Closed -$286K 144
2024
Q3
$286K Buy
+1,764
New +$281K 0.13% 104
2024
Q2
Sell
-1,594
Closed -$252K 135
2024
Q1
$252K Buy
1,594
+305
+24% +$48.5K 0.14% 111
2023
Q4
$202K Buy
+1,289
New +$198K 0.13% 118

Other funds holding JNJ

Twin Peaks Wealth Advisors's JNJ Position: Q1 2026 in Review

Twin Peaks Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 8.4% in Q1 2026, buying an estimated $49.8K and bringing the position to 2,767 shares worth $676K. The position accounts for 0.17% of the portfolio, ranked #90.

Twin Peaks Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Twin Peaks Wealth Advisors held 2,767 shares of Johnson & Johnson worth $676K as of Q1 2026.
  • Twin Peaks Wealth Advisors bought 214 Johnson & Johnson shares in Q1 2026, an estimated $49.8K.
  • Johnson & Johnson made up 0.17% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #90 holding.
  • Twin Peaks Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.